655 results

... General information about clinical trials is also available. References Brucker-Davis F, Oldfield EH, Skarulis MC, et al.: Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed ...

... patient is not a candidate for radiation therapy Hormone therapy Biological therapy Advanced or recurrent disease Immunotherapy Clinical trials FIGO = Fédération Internationale de Gynécologie et d’Obstétrique. References Martin-Hirsch PP, Bryant A, Keep SL, et ...

... as an elevated or low TSH test (normal reference range, 0.45 to 4.5 mIU/L) in the setting of normal thyroid hormone levels, and overt thyroid disease is defined by ...

... Growth monitoring to detect children with cystic fibrosis, Hormone Research, 72, 218–24, 2009 Evaluates growth monitoring to detect CF in children, but reference standard is not specified. Wald, E.R., Recurrent ...

... S., Lallemand, D., Who growth charts replacing national reference data: Their influence on screening for over-or underweight and of growth disorders, Hormone Research in Paediatrics, 82, 410, 2014 Narrative study; ...

... Since C-cell tumors are not thyroid-stimulating hormone (TSH)–dependent for growth, the T4 therapy for patients with MTC therefore may be adjusted to maintain a TSH within the normal reference range. Thyroglobulin measurement may also be useful for ...

... Treatment consists of surgery, radiation, and systemic adjuvant hormone therapy or chemotherapy. For more information, see Male Breast Cancer Treatment . In this population, screening is unlikely to be beneficial. References American Cancer Society: Cancer Facts and Figures 2024. ...

... of breast cancer, and an interest to avoid hormone replacement therapy were all related to being more likely to accept this option (cited Perez et al. as reference 229). Also added text to state that those ...

... initiation of testosterone therapy and then annually; lipid profile and liver function tests annually. Agents/circumstances to avoid : Hormone replacement therapy in those with hormone-responsive cancers; ...

... might be some short-term improvement in lipid profiles and left ventricular function with treatment, trials of thyroid hormone therapy for subclinical hypothyroidism were not suited to ...